Clinical and in vitro evidence for the antimicrobial therapy in Burkholderia cepacia complex infections

Expert Review of Anti-infective Therapy
Vikas GautamAmit Agarwal

Abstract

Treatment of infections caused by Burkholderia cepacia complex (Bcc) in cystic fibrosis (CF) patients poses a complex problem. Bcc is multidrug-resistant due to innate and acquired mechanisms of resistance. As CF patients receive multiple courses of antibiotics, susceptibility patterns of strains from CF patients may differ from those noted in strains from non-CF patients. Thus, there was a need for assessing in vitro and clinical data to guide antimicrobial therapy in these patients. A systematic search of literature, followed by extraction and analysis of available information from human and in vitro studies was done. The results of the analysis are used to address various aspects like use of antimicrobials for pulmonary and non-pulmonary infections, use of combination versus monotherapy, early eradication, duration of therapy, route of administration, management of biofilms, development of resistance during therapy, pharmacokinetics-pharmacodynamics correlations, therapy in post-transplant patients and newer drugs in Bcc-infected CF patients.

References

Sep 1, 1990·The Journal of Infectious Diseases·D M MargolisJ I Gallin
Feb 1, 1989·Antimicrobial Agents and Chemotherapy·J L BurnsD M Lien
Dec 1, 1986·Antimicrobial Agents and Chemotherapy·R A Moore, R E Hancock
Jan 1, 1987·Antimicrobial Agents and Chemotherapy·T R ParrR E Hancock
Jun 1, 1988·Antimicrobial Agents and Chemotherapy·A PrinceN X Chin
Feb 1, 1985·European Journal of Clinical Microbiology·P C FuchsR N Jones
Aug 9, 1985·The American Journal of Medicine·J L BlumerM D Reed
Feb 1, 1984·The Journal of Pediatrics·A IslesH Levison
Mar 1, 1980·Antimicrobial Agents and Chemotherapy·K HiraiS Mitsuhashi
Jul 1, 1981·Reviews of Infectious Diseases·W J MartoneR P Wenzel
May 1, 1997·American Journal of Respiratory and Critical Care Medicine·R M ArisJ R Yankaskas
Jan 1, 1997·Journal of the Royal Society of Medicine·I M Balfour-LynnB F Whitehead
Oct 24, 1997·The Journal of Antimicrobial Chemotherapy·J M Rajyaguru, M J Muszynski
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R E Hancock
Feb 19, 2000·Thorax·M J LedsonC A Hart
Apr 14, 2000·American Journal of Respiratory and Critical Care Medicine·S D AaronN E Macdonald
Dec 7, 2000·The New England Journal of Medicine·J A Lekstrom-Himes, J I Gallin
Jan 1, 1996·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Oana CiofuNiels Høiby
Mar 23, 2002·The Journal of Antimicrobial Chemotherapy·S M WigfieldJ P Burnie
Mar 29, 2002·Pediatric Pulmonology·Michael Robinson, Peter T B Bye
Apr 5, 2002·Clinical Microbiology Reviews·Jeffrey B LyczakGerald B Pier
Jun 5, 2002·Annual Review of Biochemistry·Christian R H Raetz, Chris Whitfield

❮ Previous
Next ❯

Citations

Sep 7, 2016·Frontiers in Microbiology·Yee-Chin WongSheila Nathan
Nov 5, 2016·Diagnostic Microbiology and Infectious Disease·Lorena Cristina Corrêa FehlbergAna Cristina Gales
Aug 11, 2017·The Cochrane Database of Systematic Reviews·Nishant JaiswalKiran K Thumburu
Oct 24, 2015·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Desmond Y H YapTak Mao Chan
Apr 29, 2020·The Cochrane Database of Systematic Reviews·Nishant JaiswalNikita Jaiswal
Feb 6, 2019·Annals of Clinical Microbiology and Antimicrobials·Naveen Kumar Devanga Ragupathi, Balaji Veeraraghavan
Jul 21, 2020·Pharmacotherapy·Hannah K SpencerSamuel L Aitken

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Enfermedades infecciosas y microbiología clínica
Ana Correa-RuizJuan Antonio Sáez-Nieto
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Anastasios LekkasMargaret E Hodson
The Pediatric Infectious Disease Journal
J L Burns, L Saiman
The New England Journal of Medicine
E MahenthiralingamDavid P Speert
The New England Journal of Medicine
J R Govan
© 2021 Meta ULC. All rights reserved